Skip navigation

Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12128/5054
Title: Combination of anti-vascular agent-DMXAA and HIF-1α inhibitor-digoxin inhibits the growth of melanoma tumors
Authors: Smolarczyk, Ryszard
Cichoń, Tomasz
Pilny, Ewelina
Jarosz-Biej, Magdalena
Poczkaj, Aleksandra
Kułach, Natalia
Szala, Stanisław
Keywords: tumor growth; melanoma growth
Issue Date: 2018
Citation: Scientific Reports, Vol. 8, iss. 1 (2018), art. no. 7355
Abstract: Vascular disrupting agents as DMXAA inhibit tumor growth only for a short period of time followed by rapid tumor regrowth. Among others, hypoxia and presence of transcription factor HIF-1α are responsible for tumors regrowth. The aim of our study was to investigate the inhibition of murine melanoma growth by combining two agents: anti-vascular-DMXAA and the HIF-1α inhibitor-digoxin and explaining the mechanism of action of this combination. After DMXAA treatment tumor size was reduced only for a limited time. After 7 days regrowth of tumors was observed and number of vessels was increased especially in tumor's peripheral areas. DMXAA also induced an influx of immune cells: macrophages, CD8+ cytotoxic lymphocytes, NK cells, CD4+ lymphocytes. Administration of digoxin alone inhibited the growth of tumors. Administration of both agents in the proper sequence significantly inhibited the regrowth of tumors better than either agents alone. Combination therapy reduced number of newly formed vessels. In tumors of mice treated with combination therapy, the number of macrophages M1, CD8+ cytotoxic lymphocytes, NK cells and to a lesser extent CD4+ cells was increased. The combination of anti-vascular agents with HIF-1α inhibitors appears to be an effective therapeutic option.
URI: http://hdl.handle.net/20.500.12128/5054
DOI: 10.1038/s41598-018-25688-y
ISSN: 2045-2322
Appears in Collections:Artykuły (WBiOŚ)

Files in This Item:
File Description SizeFormat 
Smolarczyk_Combination_of_anti_vascular_agent_DMXAA.pdf2,6 MBAdobe PDFView/Open
Show full item record


Uznanie Autorstwa 3.0 Polska Creative Commons License Creative Commons